MARKET

BHC

BHC

Bausch Health Companies Inc
NYSE
5.01
+0.05
+0.93%
Opening 14:00 03/16 EDT
OPEN
5.00
PREV CLOSE
4.960
HIGH
5.08
LOW
4.980
VOLUME
740.79K
TURNOVER
--
52 WEEK HIGH
8.69
52 WEEK LOW
4.250
MARKET CAP
1.86B
P/E (TTM)
11.96
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BHC last week (0309-0313)?
Weekly Report · 7h ago
Weekly Report: what happened at BHC last week (0302-0306)?
Weekly Report · 03/09 10:28
RSI Alert: Bausch Health Companies (BHC) Now Oversold
NASDAQ · 03/06 17:04
Cooper Companies raises 2026 profit forecast on demand for disposable contact lenses
Reuters · 03/05 22:52
Bausch + Lomb Director Thomas W. Ross Sr. Acquires Common Shares
Reuters · 03/04 21:19
Xifaxan Win And Bausch Plus Lomb Spinoff Plans Reframe Bausch Health
Simply Wall St · 03/04 02:32
Bausch EVP and General Counsel Seana Carson Reports Disposal of Bausch Health Common Shares
Reuters · 03/03 22:51
Bausch + Lomb Director Alfonso Eduardo Acquires Common Shares
Reuters · 03/03 22:19
More
About BHC
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.

Webull offers Bausch Health Companies Inc stock information, including NYSE: BHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BHC stock methods without spending real money on the virtual paper trading platform.